Dr. Durand Discusses Treatment Options for Toxicities from Therapy in HER2+ Breast Cancer
April 2nd 2018Jean-Bernard Durand, MD, professor in the Department of Cardiology at The University of Texas MD Anderson Cancer Center, discusses advice for community oncologists on managing patients that are experiencing symptoms from treatment for HER2-positive breast cancer.
Read More
Dr. Durand on Anthracyclines in Treatments for HER2+ Breast Cancer
March 16th 2018Jean-Bernard Durand, MD, associate professor in the Department of Cardiology at The University of Texas MD Anderson Cancer Center, discusses protecting patients’ hearts from anthracyclines and HER2-targeted therapies when treating for HER2-positive breast cancer.
Read More
Dr. Durand on the Management of Rhythm Disturbances Using Web-Based Technologies
February 12th 2018Jean-Bernard Durand, MD, medical director of Cardiomyopathy Services, director of Cardiovascular Genetics Research, The University of Texas MD Anderson Cancer Center, discusses web-based management technologies for patients with cancer.
Read More
Dr. Durand on Web-Based Management Technologies for Patients With Cancer
January 10th 2018Jean-Bernard Durand, MD, Medical Director of Cardiomyopathy Services, Director of Cardiovascular Genetics Research, The University of Texas MD Anderson Cancer Center, discusses web-based management technologies for patients with cancer.
Read More